AC Motor High Air Compressor Pump Head 370W Oil Free Air Compressor

Name: AC Motor High Air Compressor Pump Head 370W Oil Free Air Compressor
Brand: Sinc Gleeman Medical Technology(Changzhou) Co.,Ltd.
SKU: 1943079655

Jiangsu, ChinaSinc Gleeman Medical Technology(Changzhou) Co.,Ltd.

US$85.00

1-999 Pieces

US$80.00

1,000-2,999 Pieces

US$78.00

3,000-4,999 Pieces

US$75.00

5,000+ Pieces

Sample price:US$40.00/piece.Request sample

Product profile

Customization

Available

Warranty

Two Years

Lubrication Style

Oil-free

Model NO.

GLE550A-1

Cooling System

Air Cooling

Cylinder Arrangement

Duplex Arrangement

Cylinder Position

Two Air Compressor

Structure Type

Semi-Closed Type

Compress Level

Double-Stage

Refrigerant Type

Oil Free Air Compressor

Brand Name

OEM

Voltage

220V 50Hz

Power

≦550W

Capacity

50 L/Min @ 1.4 Bar

Air Flow Rate

≧130L/Min @ 2 Bar

Speed

1440rpm

Temperature

-5℃-40℃

Thermal Protector

135℃

Noise

≤58dB(a)

Rate Working Pressure

30 Psi ( 2 Bar )

Transport Package

2 Layers Carton Box + Wooden Pallet

Specification

240*113*200 mm

Origin

China

Key features

Oil-Free Operation: Features oil-free lubrication style for clean air output and reduced maintenance.

High Efficiency Power: 370W AC motor with 1440rpm speed and 50 L/Min capacity at 1.4 Bar.

Dual Cylinder Design: Duplex arrangement with two cylinders for stable and powerful air compression.

Compact & Portable: Lightweight 10.4 kg design with dimensions 240*113*200 mm for easy installation.

Customizable OEM: Supports OEM branding and custom voltage options for specific market needs.

Reliable Warranty: Comes with a two-year warranty to ensure product quality and customer peace of mind.

Company profile

Sinc Gleeman Medical Technology(Changzhou) Co.,Ltd.

Jiangsu, China

Business Type: Manufacturer/Factory, Trading CompanyExport Year: 2020-06-11Nearest Port: ShanghaiAverage Response Time: ≤6.56hTerms of Payment: LC, T/T, D/P, etc.International Commercial Terms(Incoterms): FOB, EXW, CIF, DDP

AI-Powered supplier vetting

SummarySinc Gleeman Medical Technology (Changzhou) Co., Ltd. is identified as both a trading company and manufacturer/factory in China. The supplier reports substantial manufacturing infrastructure, including over 600 employees, a 61,000-square-meter facility, more than 10 production lines, vertical integration, and stated annual capacity of 4,000,000 oil-free air pumps. It exports to multiple regions and holds ISO 9001 and ISO 14001 certifications. The supplier also states that it supports OEM/ODM partnerships. However, many operational, R&D, service, traceability, and contract-related fields remain unknown. An SGS audit is documented with a validity period from June 18, 2024 to June 17, 2025, but the provided audit result code is not interpretable as a substantive performance conclusion.

Supplier typeThe supplier is explicitly classified as both a Trading Company and Manufacturer/Factory. Its stated die-casting, motor production, CNC finishing, automatic assembly, and vertically integrated supply-chain operations support the presence of manufacturing capability rather than trading-only activity.

CertificationsThe supplier reports ISO 14001 and ISO 9001 certification. An SGS audit is also documented, with a stated validity period from 2024-06-18 to 2025-06-17; however, the supplied audit result value is not sufficiently explained to assess the audit outcome.

Production capacityProduction capability is supported by more than 10 production lines, over 600 employees, a 61,000-square-meter factory, full production facilities and testing instruments, vertical integration, and stated annual capacity of 4,000,000 oil-free air pumps. The supplier also reports 3,000,000 oxygen concentrator compressor pieces in annual output information.

Customization capabilityThe supplier explicitly states that it works with global intelligent product brand owners, retailers, and distributors to establish OEM/ODM partnerships. However, the dedicated OEM capability, ODM service availability, and related R&D service fields are otherwise marked unknown, so the evidence confirms stated partnership intent but not the full scope of customization execution.